Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity-Reference-Cited by-同舟云学术

Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity

Published:2024-05 Issue:5 Volume:36 Page:1013-1029.e5
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Tong Lingfeng,Chen Zhangbing,Li Yangyang,Wang Xinxia,Yang Changjie,Li Yakui,Zhu Yemin,Lu Ying,Liu Qi,Xu Nannan,Shao Sijia,Wu Lifang,Zhang Ping,Wu Guangyu,Wu Xiaoyu,Chen Xiaosong,Fang Junwei,Jia Renbing,Xu Tianle,Li Bin,Zheng Liang,Liu Junling,Tong Xuemei

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference52 articles.

1. Nonalcoholic fatty liver disease;Brunt;Nat. Rev. Dis. Primers,2015

2. Management of NAFLD: a stage-based approach;Rinella;Nat. Rev. Gastroenterol. Hepatol.,2016

3. Nonalcoholic Steatohepatitis: A Review;Sheka;JAMA,2020

4. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease;Eslam;Gastroenterology,2020

5. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement;Eslam;J. Hepatol.,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural and systems characterization of phosphorylation on metabolic enzymes identifies sex-specific metabolic reprogramming in obesity;2024-08-29

2. Dietary supplementation with grape seed extract improves energy metabolism by enhancing the production of inosine in the rumen of dairy cows;2024-08-07

3. Targeting Liver Xor by GalNAc-siRNA Is an Effective Strategy for Hyperuricemia Therapy;Pharmaceutics;2024-07-14

4. CD9 Counteracts Liver Steatosis and Mediates GCGR Agonist Hepatic Effects;Advanced Science;2024-06-05